Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Anavasi Diagnostics has raised $6.0M in total funding. The most recent round was Convertible Note. The last funding was announced in January 2022.
Anavasi Diagnostics's investors include National Institutes of Health.
Anavasi Diagnostics is headquartered in Seattle, United States.
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing.
Anavasi Diagnostics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anavasi Diagnostics — Funding & Investors." VCBacked, January 12, 2022, https://www.vcbacked.co/company/anavasi-diagnostics. Accessed October 26, 2026.
VCBacked. (2022). Anavasi Diagnostics — Funding & Investors. Retrieved October 26, 2026, from https://www.vcbacked.co/company/anavasi-diagnostics
{{cite web |title=Anavasi Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/anavasi-diagnostics |website=VCBacked |access-date=October 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated